REPORT ID 6602

EMEA (Europe, Middle East and Africa) Gastrointestinal Drugs Market Report 2017

Publish Date
26-Dec-17
Pages
100
Format
Electronic (PDF)

In this report, the EMEA Gastrointestinal Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (Units), revenue (Million USD), market share and growth rate of Gastrointestinal Drugs for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Gastrointestinal Drugs market competition by top manufacturers/players, with Gastrointestinal Drugs sales volume (Units), price (K USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    AstraZeneca
    Johnson & Johnson
    Salix Pharma
    Takeda Pharma
    Eisai
    Shire
    Allergan
    ...

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Capsules
    Inhalants
    Parenterals
    Tablets
    Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Antacid & Anti-Ulcerant
    GIT Anti-inflammatory
    Antiemetic
    Anti-diarrhoea
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Gastrointestinal Drugs Market Report 2017
1 Gastrointestinal Drugs Overview
    1.1 Product Overview and Scope of Gastrointestinal Drugs
    1.2 Classification of Gastrointestinal Drugs
        1.2.1 EMEA Gastrointestinal Drugs Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Gastrointestinal Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Capsules
        1.2.4 Inhalants
        1.2.5 Parenterals
        1.2.6 Tablets
        1.2.7 Other
    1.3 EMEA Gastrointestinal Drugs Market by Application/End Users
        1.3.1 EMEA Gastrointestinal Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Antacid & Anti-Ulcerant
        1.3.3 GIT Anti-inflammatory
        1.3.4 Antiemetic
        1.3.5 Anti-diarrhoea
        1.3.6 Other
    1.4 EMEA Gastrointestinal Drugs Market by Region
        1.4.1 EMEA Gastrointestinal Drugs Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Gastrointestinal Drugs (2012-2022)
        1.5.1 EMEA Gastrointestinal Drugs Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Gastrointestinal Drugs Revenue and Growth Rate (2012-2022)

2 EMEA Gastrointestinal Drugs Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Gastrointestinal Drugs Market Competition by Players/Manufacturers
        2.1.1 EMEA Gastrointestinal Drugs Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Gastrointestinal Drugs Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Gastrointestinal Drugs Sale Price by Players (2012-2017)
    2.2 EMEA Gastrointestinal Drugs (Volume and Value) by Type/Product Category
        2.2.1 EMEA Gastrointestinal Drugs Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Gastrointestinal Drugs Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Gastrointestinal Drugs Sale Price by Type (2012-2017)
    2.3 EMEA Gastrointestinal Drugs (Volume) by Application
    2.4 EMEA Gastrointestinal Drugs (Volume and Value) by Region
        2.4.1 EMEA Gastrointestinal Drugs Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Gastrointestinal Drugs Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Gastrointestinal Drugs Sales Price by Region (2012-2017)

3 Europe Gastrointestinal Drugs (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Gastrointestinal Drugs Sales and Value (2012-2017)
        3.1.1 Europe Gastrointestinal Drugs Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Gastrointestinal Drugs Revenue and Growth Rate (2012-2017)
    3.2 Europe Gastrointestinal Drugs Sales and Market Share by Type
    3.3 Europe Gastrointestinal Drugs Sales and Market Share by Application
    3.4 Europe Gastrointestinal Drugs Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Gastrointestinal Drugs Sales Volume by Countries (2012-2017)
        3.4.2 Europe Gastrointestinal Drugs Revenue by Countries (2012-2017)
        3.4.3 Germany Gastrointestinal Drugs Sales and Growth Rate (2012-2017)
        3.4.4 France Gastrointestinal Drugs Sales and Growth Rate (2012-2017)
        3.4.5 UK Gastrointestinal Drugs Sales and Growth Rate (2012-2017)
        3.4.6 Russia Gastrointestinal Drugs Sales and Growth Rate (2012-2017)
        3.4.7 Italy Gastrointestinal Drugs Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Gastrointestinal Drugs Sales and Growth Rate (2012-2017)

4 Middle East Gastrointestinal Drugs (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Gastrointestinal Drugs Sales and Value (2012-2017)
        4.1.1 Middle East Gastrointestinal Drugs Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Gastrointestinal Drugs Revenue and Growth Rate (2012-2017)
    4.2 Middle East Gastrointestinal Drugs Sales and Market Share by Type
    4.3 Middle East Gastrointestinal Drugs Sales and Market Share by Application
    4.4 Middle East Gastrointestinal Drugs Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Gastrointestinal Drugs Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Gastrointestinal Drugs Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Gastrointestinal Drugs Sales and Growth Rate (2012-2017)
        4.4.4 Israel Gastrointestinal Drugs Sales and Growth Rate (2012-2017)
        4.4.5 UAE Gastrointestinal Drugs Sales and Growth Rate (2012-2017)
        4.4.6 Iran Gastrointestinal Drugs Sales and Growth Rate (2012-2017)

5 Africa Gastrointestinal Drugs (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Gastrointestinal Drugs Sales and Value (2012-2017)
        5.1.1 Africa Gastrointestinal Drugs Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Gastrointestinal Drugs Revenue and Growth Rate (2012-2017)
    5.2 Africa Gastrointestinal Drugs Sales and Market Share by Type
    5.3 Africa Gastrointestinal Drugs Sales and Market Share by Application
    5.4 Africa Gastrointestinal Drugs Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Gastrointestinal Drugs Sales Volume by Countries (2012-2017)
        5.4.2 Africa Gastrointestinal Drugs Revenue by Countries (2012-2017)
        5.4.3 South Africa Gastrointestinal Drugs Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Gastrointestinal Drugs Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Gastrointestinal Drugs Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Gastrointestinal Drugs Sales and Growth Rate (2012-2017)

6 EMEA Gastrointestinal Drugs Manufacturers/Players Profiles and Sales Data
    6.1 AstraZeneca
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Gastrointestinal Drugs Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 AstraZeneca Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Johnson & Johnson
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Gastrointestinal Drugs Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Johnson & Johnson Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Salix Pharma
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Gastrointestinal Drugs Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Salix Pharma Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Takeda Pharma
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Gastrointestinal Drugs Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Takeda Pharma Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Eisai
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Gastrointestinal Drugs Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Eisai Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Shire
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Gastrointestinal Drugs Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Shire Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Allergan
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Gastrointestinal Drugs Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Allergan Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    ...

7 Gastrointestinal Drugs Manufacturing Cost Analysis
    7.1 Gastrointestinal Drugs Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Gastrointestinal Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Gastrointestinal Drugs Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Gastrointestinal Drugs Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Gastrointestinal Drugs Market Forecast (2017-2022)
    11.1 EMEA Gastrointestinal Drugs Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Gastrointestinal Drugs Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Gastrointestinal Drugs Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Gastrointestinal Drugs Price and Trend Forecast (2017-2022)
    11.2 EMEA Gastrointestinal Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Gastrointestinal Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Gastrointestinal Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Gastrointestinal Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Gastrointestinal Drugs Sales Forecast by Type (2017-2022)
    11.7 EMEA Gastrointestinal Drugs Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer